Primary prevention of epilepsy in patients with different epileptogenic conditions

Expert Review of Neurotherapeutics

Volumn 4, Issue 6, 2004, Pages 945-952

  Beghi, Ettore ^a,b   Beghi, Massimiliano ^a,b   Cornaggia, Cesare ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Antiepileptic drugs; CNS injuries; Epilepsy; Epileptogenesis; Prevention; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ANIMAL MODEL; BONE MARROW SUPPRESSION; BRAIN DISEASE; BRAIN TUMOR; CLINICAL TRIAL; CRANIOTOMY; DISEASE CONTROL; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; HEAD INJURY; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; KINDLING; META ANALYSIS; NAUSEA; NERVE CELL LESION; NEUROSURGERY; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIMARY PREVENTION; PROPHYLAXIS; RASH; REMISSION; REVIEW; SEIZURE; SIDE EFFECT; SYSTEMATIC REVIEW; VOMITING;

ANIMALS; ANTICONVULSANTS; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; DRUG EVALUATION; EPILEPSY; FOLLOW-UP STUDIES; HUMANS; RISK; SEIZURES;

EID: 8344265249     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.4.6.945     Document Type: Review

References (44)

1. International League Against Epilepsy. Commission on epidemiology and prognosis. Guidelines for epidemiologic studies on epilepsy. Epilepsia 34, 592-596 (1993).
2. Willmore LJ. Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 31(Suppl. 5), S67-S73 (1990).
3. Frey LC. Epidemiology of postttraumatic epilepsy: a critical review. Epilepsia 44(Suppl. 10), 11-17 (2003).
4. Weiss GH, Salazar AM, Vance SC et al. Predicting post-traumatic epilepsy in penetrating head injury. Arch. Neurol. 43, 771-773 (1986).
5. Shaw MDM, Foy PM. Epilepsy after craniotomy and the place of prophylactic anticonvulsant drugs: discussion paper. JR Soc. Med. 84, 221-223 (1991).
6. Posner JB. Neurologic Complications of Cancer. FA Davis, PA, USA (1995).
7. Cascino GD. Epilepsy and brain tumors: implications for treatment. Epilepsia 31(Suppl. 3), S37-S44 (1990).
8. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 38, 1407-1410 (1988).
9. So E, Annegers J, Hauser W, O'Brien P, Whisnant M. Population-based study of seizure disorders after cerebral infarction. Neurology 46, 350-355 (1996).
10. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Epileptic seizures after a first stroke: the Oxfordshire community stroke project. Br. Med. J. 315, 1582-1587 (1997).
11. Adams HP, Adams RJ, Brott T et al. Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34, 1056-1083 (2003).
12. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology 46, 727-730 (1996).
13. Olafsson E, Benedikz J, Hauser WA. Risk of epilepsy in patients with multiple sclerosis: a population-based study in Iceland. Epilepsia 40, 745-747 (1999).
14. Jutila L, Immonen A, Partanen K et al. Neurobiology of epileptogenesis in the temporal lobe. Adv. Tech. Stand. Neurosurg. 27, 3-22 (2002).
15. Pitkanen A, Sutula T. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal lobe epilepsy. Lancet Neurol. 1, 173-181 (2002).
16. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N. Engl. J. Med. 342, 314-319 (2000).
17. Annegers JF, Hauser WA, Elvebalk LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia 30, 729-37 (1979).
18. Collaborative Group for the Study of Epilepsy. Prognosis of epilepsy in newly referred patients: a multicenter prospective study. Epilepsia 29, 236-243 (1988).
19. Shinnar S, Berg AT, O'Dell C et al. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann. Neurol. 48, 140-147 (2000).
20. MacDonald BK, Johnson AL, Goodridge DM et al. Factors predicting prognosis of epilepsy after presentation with seizures. Ann. Neurol. 48, 833-841 (2000).
21. Musicco M, Beghi E, Solari A, Viani F, for the First Seizure Trial Group (FIRST Group). Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. Neurology 49, 991-998 (1997).
22. Camfield P, Camfield C, Smith S et al. Long-term outcome is unchanged by antiepileptic drug treatment after a first seizure: a 15-year follow-up from a randomized trial in childhood. Epilepsia 43, 662-663 (2002).
23. Loscher W. Animal models of intractable epilepsy. Prog. Neurobiol. 53, 239-258 (1997).
24. Yang L, Benardo LS. Valproate prevents epileptiform activity after trauma in an in vitro model in neocortical slices. Epilepsia 41, 1503-1513 (2000).
25. Pitkanen A. Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models. Epilepsy Res. 50, 141-160 (2002). Comprehensive review of the results of experiments performed in animal models on the antiepileptogenic properties of antiepileptic drugs (AEDs).
26. McNamara JO. Analysis of the molecular basis of kindling development. Psychiatry Clin. Neurosci. 49, 175-178 (1995).
27. Nissinen JPT, Narkilahti S, Lukasiuk K, Pitkanen A. Diazepam treatment has a disease-modifying effect on the developing epilepsy after status epilepticus in rat. Epilepsia 42(Suppl.), 131 (2001). The only study showing that epileptogenesis can be prevented in a subpopulation of experimental animals.
28. Temkin NR, Dikmen SS, Winn HR. Clinical trials for seizure prevention. In: Antiepileptic Drug Development. French J, Leppik I, Dichter MA (Eds). Adv. Neurol. (Volume 76). Lippincott-Raven Publishers, PA, USA, 179-188 (1998).
29. Pechadre JC, Lauxerois M, Colnet G et al. Prevention de l'epilepsie post-traumatique tardive par phenytoine dans les traumatismes craniens graves. Presse Med. 20, 841-845 (1991).
30. Young B, Rapp RP, Norton JA et al. Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J. Neurosurg. 58, 231-235 (1983a).
31. Young B, Rapp RP, Norton JA et al. Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J. Neurosurg. 58, 236-241 (1983b).
32. Schierhout G, Roberts I. Prophylactic antiepileptic agents after head injury: a systematic review. J. Neurol. Neurosurg. Psychiatry 64, 108-112 (1998).
33. Schierhout G, Roberts I. Antiepileptic drugs for preventing seizures following acute traumatic brain injury. The Cochrane Library, Issue 3 (2004). Updated meta-analysis of randomized trials for primary prevention of seizures and epilepsy in patients with head trauma.
34. McQueen JK, Blackwood BH, Harris P, Kalbag RM, Johnson AL. Low risk of late post-traumatic seizures following severe head injury: implication for clinical trials of prophylaxis. J. Neurol. Neurosurg. Psychiatry 46, 899-904 (1983).
35. Temkin NR, Dikmen SS, Wilensky AJ et al. A randomized double-blind study of phenytoin for the prevention of post-traumatic seizures. N. Engl. J. Med. 323, 497-502 (1990).
36. Dikmen SS, Temkin NR, Miller B, Machamer J, Winn HR. Neurobehavioral effects of phenytoin prophylaxis of post-traumatic seizures. JAMA 265, 1271-1277 (1991).
37. Glantz MJ, Cole BF, Forsyth PA et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 54, 1886-1893 (2000). Provides evidence-based guidelines for AED prophylaxis in patients with newly diagnosed brain tumors.
38. Kuijlen JMA, Teernstra OPM, Kessels AGH et al. Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure 5, 291-298 (1996).
39. North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB. Phenytoin and postoperative epilepsy. A double-blind study. J. Neurosurg. 58, 672-677 (1983).
40. Foy PM, Chadwick DW, Rajgopalan N, Johnson AL, Shaw MDM. Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J. Neurol. Neurosurg. Psychiatry 55, 753-757 (1992).
41. De Santis A, Villani R, Sinisi M, Stocchetti N, Perucca E. Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study. Epilepsia 43, 175-182 (2002).
42. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42, 515-524 (2001). Comprehensive systematic review of published randomized trials for seizure prevention in several epileptogenic conditions.
43. Meremikwu M, Marson AG. Routine anticonvulsants for treating cerebral malaria. The Cochrane Library, Issue 3 (2004).
44. Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury. Neurology 60, 10-16 (2003). Provides evidence-based guidelines for AED prophylaxis in patients with traumatic brain injury.